FIELD: medicine, oncology. SUBSTANCE: invention relates to application of compounds of the formula (I) or their pharmaceutically acceptable salts for preparing a medicinal agent used for treatment or prophylaxis of large intestine, lungs or stomach cancer and to method for treatment of indicated diseases also by administration of compounds of the formula (I). Compounds show high anticancer activity. EFFECT: enhanced and valuable medicinal properties of agent. 14 cl, 3 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE | 1998 |
|
RU2196141C2 |
ANTICANCER PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2419430C2 |
NOVEL DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS MEDICAMENTS | 2002 |
|
RU2294326C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
PYRAZOLE DERIVATIVES FOR TREATMENT OF VIRAL DISEASES | 2001 |
|
RU2270832C2 |
METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE | 2001 |
|
RU2281094C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
COMPOUNDS OF THIENYL[3, 2-d]PYRIMIDINE-4-ON, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2012 |
|
RU2624021C2 |
AMINOPYRIMIDINE KINASE INHIBITORS | 2010 |
|
RU2636589C2 |
PYRAZOLE PYRIDINE DERIVATIVES AS NADPH-OXIDASE | 2009 |
|
RU2548022C2 |
Authors
Dates
2003-12-27—Published
2000-07-19—Filed